Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Calcitonin (elcatonin [eCT]) has been used mainly for hypercalcemia and pain associated with osteoporosis.
|
30655691 |
2019 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The patient had longstanding hypercalcaemia and hyperparathyrodism refractory to calcimimetics, calcitonin, hormone and haemodialysis.
|
31088386 |
2019 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Twenty-one patients with EPNS were detected: 16 with ectopic Cushing's syndrome (ECS), one with hypercalcaemia due to parathyroid hormone-related protein (PTHrP) secretion, three with hypercalcitonaemia and one patient with dual secretion of calcitonin and beta-human chorionic gonadotropin (β-HCG).
|
30280284 |
2019 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The patient was started on aggressive intravenous fluid hydration and intravenous calcitonin, after which her altered mental status resolved and both kidney function and hypercalcemia improved.
|
29480854 |
2018 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Her condition was complicated by hypercalcemia resistant to prolonged medical treatment with hyperhydration, diuretic and steroid but eventually the infant responded to high doses of calcitonin.
|
29915859 |
2018 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Rebound hypercalcemia (serum calcium, 3.1 to 4.3 mmol/L) was unresponsive to hyperhydration alone, requiring repeated doses of calcitonin or intravenous bisphosphonate treatment.
|
29211870 |
2018 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Treatment with calcitonin and cinacalcet could not control hypercalcemia.
|
29658374 |
2018 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The baby was managed symptomatically and specific treatment like pamidronate, calcitonin and steroid therapy were also administered to reduce hypercalcaemia.
|
30262523 |
2018 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
His hypercalcemia continued to worsen with the initiation of MAI therapy but we were able to treat it successfully with pamidronate and calcitonin.
|
27620657 |
2017 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our findings furthermore suggest that the tumoral production of calcitonin and PTHrP might have contributed to the increased bone mineral storage of calcium and thus probably attenuated the development of frank hypercalcemia.
|
17188588 |
2007 |
Hypercalcemia
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.
|
12637657 |
2003 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
In the patient with JD, the hypercalcemia was of early onset; chronic and nonprogressive; refractory to the administration of phosphate, glucocorticoid, and calcitonin; and accompanied by suppressed PTH levels as determined by two different immunoassays, an undetectable PTHrP level, increased excretion of nephrogenous cAMP (an in vivo bioassay of endogenous PTH production), decreased tubular reabsorption of phosphate, increased tubular reabsorption of calcium, increased biochemical indexes of bone turnover, and increased histological indexes of bone turnover on iliac bone histomorphometry after double tetracycline labeling.
|
8855805 |
1996 |
Hypercalcemia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Involvement of the calcitonin/CGRP gene in Williams syndrome is postulated on the basis that Williams syndrome children often have infantile hypercalcemia and deficient expression of calcitonin, a hormone that lowers serum calcium levels.
|
1867260 |
1991 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia.
|
1938595 |
1991 |
Hypercalcemia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The calcitonin-CGRP gene in the infantile hypercalcaemia/Williams-Beuren syndrome.
|
2486208 |
1989 |
Hypercalcemia
|
0.400 |
Therapeutic
|
disease |
CTD_human |
Vitamin D intoxication in an anephric child.
|
1115441 |
1975 |